Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pharmacophore discovery--lessons learned.

John H van Drie1

  • 1Vertex Pharmaceuticals, 130 Waverly St., Cambridge, MA 02139, USA. vandrie@mindspring.com

Current Pharmaceutical Design
|July 23, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hit diffusion: limitations to drug discovery and structure-based design.

Journal of computer-aided molecular design·2021
Same author

Cryo-EM as a powerful tool for drug discovery.

Bioorganic & medicinal chemistry letters·2020
Same author

Author Correction: Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.

Nature·2018
Same author

Discovery of Spiro Oxazolidinediones as Selective, Orally Bioavailable Inhibitors of p300/CBP Histone Acetyltransferases.

ACS medicinal chemistry letters·2018
Same author

Discovery of a selective catalytic p300/CBP inhibitor that targets lineage-specific tumours.

Nature·2017
Same author

Protein folding, protein homeostasis, and cancer.

Chinese journal of cancer·2011
Same journal

Overcoming Physiological Barriers in Brain Tumor Therapy: Advances in Nanomedicine, Ultramolecular Pharmaceuticals, and Targeted Drug Delivery.

Current pharmaceutical design·2026
Same journal

Breathing Life into Research: The Transformative Potential of Lung-on-a-Chip Technology.

Current pharmaceutical design·2026
Same journal

Cross-Tissue Transcriptome-Wide Association Study Prioritizes Candidate Genes and Compound-Associated Signatures for Osteoarthritis.

Current pharmaceutical design·2026
Same journal

Emerging Role of AI in Gastroenterology and Hepatology: Revolutionizing Medical Device-Assisted Diagnosis.

Current pharmaceutical design·2026
Same journal

Nanostructured Lipid Carriers in Drug Targeting: Characterization, Patents, and Recent Innovations.

Current pharmaceutical design·2026
Same journal

Corrigendum to: miRNA in Diagnosis and Therapeutics of Tuberculosis: Importance in Latent and Brain Associated Pathologies.

Current pharmaceutical design·2026
See all related articles

Pharmacophore discovery is crucial for drug design when structural data is unavailable. This review summarizes a decade of challenges and offers practical tips for the DANTE methodology in drug discovery.

Area of Science:

  • Computational chemistry
  • Medicinal chemistry
  • Drug discovery

Background:

  • Pharmacophore discovery is essential for molecular modeling without X-ray structural data.
  • Initially used for lead discovery, pharmacophores are now vital in lead optimization and 3D-QSAR.
  • This review synthesizes over a decade of experience in applying pharmacophore discovery to real-world drug discovery challenges.

Purpose of the Study:

  • To review the challenges and successes of pharmacophore discovery in drug discovery over the past decade.
  • To provide practical guidance on utilizing the DANTE methodology for pharmacophore discovery.
  • To highlight the evolution of pharmacophore applications from lead discovery to lead optimization.

Main Methods:

  • Review of a decade of pharmacophore discovery experiences.

Related Experiment Videos

  • Description of the DANTE methodology for pharmacophore discovery.
  • Application of pharmacophore discovery in lead discovery and optimization.

    • Main Results:

    • Summarization of challenges encountered and solutions found in pharmacophore discovery.
    • Presentation of practical tips for implementing the DANTE methodology.
    • Demonstration of pharmacophore utility in various stages of drug discovery.

    Conclusions:

    • Pharmacophore discovery remains a key technique in molecular modeling, especially with limited structural data.
    • The DANTE methodology offers a practical approach to pharmacophore discovery.
    • Continued application and refinement of pharmacophore discovery enhance lead optimization and drug design.